Supportive Expressive Therapy for Depressed and Anxious Adolescents

Center for Addiction and Mental Health (CAMH)

Status: Completed

Conditions: Depression; Anxiety

Treatments: Other: Supportive Expressive Therapy

Study type: Interventional

Funder types: Other

Identifiers

NCT00381979

169/2003

Details and patient eligibility

About

The purpose of the study is to investigate the effectiveness of providing Supportive Expressive Therapy to adolescents who are depressed and/or anxious.

Full description

Supportive Expressive Therapy (SET; a 16 session manualized form of psychodynamic therapy) has been well utilized with adult clients. To date, there is no known systematic study into the benefit of this method of therapy with adolescents who are depressed and/or anxious. It is thought that SET would be useful for this population as it is similar in principle to Interpersonal Relationship Therapy (IPT), which has been shown to be effective for use with depressed adults and youth. Both IPT and SET help clients explore the role they play within challenging relationships in their lives. SET, however, allows for the exploration of more relationships within the adolescents' circle. Moreover, SET explores the adolescents' perceptions of themselves, others, and their wish in relationships. Further, the SET method is more easily individualized in that it affords greater flexibility in design and possibility for change over time. Accordingly, the purpose of this study is to explore the feasibility of utilizing this method of therapy with adolescents who are depressed and anxious. We will be exploring the effectiveness of SET through the resolution of depressed and/or anxious adolescents' conflictual relationships thereby reducing their symptomatology.

Enrollment: 20 patients

Sex: All

Ages: 15 to 24 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• 15-24 year old, male & female adolescents, primary diagnosis of depression or anxiety disorder.
• Clients with co-morbid diagnoses, suicidal ideation or taking medication would not necessarily be excluded if deemed able to partake in the proposed therapy.
• Medication dose needs to be stable for 4-6 weeks prior to starting therapy.

Exclusion criteria

• Clients who are actively psychotic, developmentally delayed, or have a diagnosis of bipolar disorder.
• Clients who are not fluent in English.

Trial design

Primary purpose: Treatment

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

20 participants in 1 patient group

1

Experimental group

Description:

set

Treatment:

Other: Supportive Expressive Therapy